Redefining Metabolic Dysfunction-Associated Steatohepatitis Treatment: Managed Care Insights on New Therapies Targeting Metabolic Dysfunction

Author: Jeffrey Casberg, MS, RPh

Jeffrey Casberg, MS, RPh, Executive Vice President of Clinical Pharmacy at IPD Analytics, joined the AMCP Northeast Evening of Education panel on May 14, 2026. Alongside fellow expert panelists, Jeff shared managed care strategies and insights on emerging therapies targeting metabolic dysfunction, with a focus on metabolic dysfunction-associated steatohepatitis.